Optical techniques for tracking multiple myeloma engraftment, growth, and response to therapy

Journal of Biomedical Optics

Volumn 16, Issue 1, 2011, Pages

  Runnels, Judith M ^a,b,c   Carlson, Alicia L ^a,c   Pitsillides, Costas ^a   Thompson, Brian ^a   Wu, Juwell ^a   Spencer, Joel A ^a   Kohler, John M J ^a   Azab, Abdelkareem ^b,c   Moreau, Anne Sophie ^b,c   Rodig, Scott J ^d   Kung, Andrew L ^b,c,e   Anderson, Kenneth C ^b   Ghobrial, Irene M ^b   Lin, Charles P ^a,c  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b DANA FARBER CANCER INSTITUTE   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d BRIGHAM AND WOMEN S HOSPITAL   (United States)

^e BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

bioluminescence; confocal microscopy; In vivo cell tracking; in vivo flow cytometry; intravital imaging; multiple myeloma

Indexed keywords

BIOLUMINESCENCE IMAGING; BONE MARROW; CANCER CELLS; CELLULAR PROCESS; CIRCULATING TUMOR CELLS; DISEASE PROCESS; ENGRAFTMENT; FLUORESCENT REPORTER; HEMATOLOGICAL MALIGNANCIES; IMAGING METHOD; IN VIVO CELL TRACKING; IN-VIVO; INTRAVITAL IMAGING; INTRAVITAL MICROSCOPY; LATE STAGE; MULTIPLE MYELOMA; OPTICAL TECHNIQUE; SINGLE SITES; THERAPEUTIC INTERVENTION; THERAPEUTIC STRATEGY; TUMOR GROWTH;

BIOLUMINESCENCE; CONFOCAL MICROSCOPY; DRUG THERAPY; FLOW CYTOMETRY; GRAFTS; PHOSPHORESCENCE; TUMORS;

CELLS;

ANTINEOPLASTIC AGENT; BORONIC ACID DERIVATIVE; BORTEZOMIB; PYRAZINE DERIVATIVE;

ANIMAL; ARTICLE; BAGG ALBINO MOUSE; CELL TRACKING; FEMALE; FLOW CYTOMETRY; FLUORESCENCE MICROSCOPY; MALE; METHODOLOGY; MOUSE; MOUSE MUTANT; MULTIPLE MYELOMA; PATHOLOGY; PATHOPHYSIOLOGY; TREATMENT OUTCOME; TUMOR CELL LINE;

ANIMALS; ANTINEOPLASTIC AGENTS; BORONIC ACIDS; CELL LINE, TUMOR; CELL TRACKING; FEMALE; FLOW CYTOMETRY; MALE; MICE; MICE, INBRED BALB C; MICE, SCID; MICROSCOPY, FLUORESCENCE; MULTIPLE MYELOMA; PYRAZINES; TREATMENT OUTCOME;

EID: 79955954539     PISSN: 10833668     EISSN: 15602281     Source Type: Journal    
DOI: 10.1117/1.3520571     Document Type: Article

References (70)

1. D. R. Welch, " Technical considerations for studying cancer metastasis in vivo.," Clin. Exp. Metastasis 15 (3), 272-306 (1997). 10.1023/A:1018477516367 (Pubitemid 27240358)
2. T. Wilson and J. W. Hastings, " Bioluminescence.," Ann. Rev. Cell Dev. Biol. 14, 197-230 (1998). 10.1146/annurev.cellbio.14.1.197 (Pubitemid 29001454)
3. J. Y. Adams, M. Johnson, M. Sato, F. Berger, S. S. Gambhir, M. Carey, M. L. Iruela-Arispe, and L. Wu, " Visualization of advanced human prostate cancer lesions in living mice by a targeted gene transfer vector and optical imaging.," Nat. Med. 8 (8), 891-897 (2002).
4. S. Bhaumik and S. S. Gambhir, " Optical imaging of Renilla luciferase reporter gene expression in living mice.," Proc. Natl. Acad. Sci. USA 99 (1), 377-382 (2002). 10.1073/pnas.012611099 (Pubitemid 34060369)
5. C. H. Contag, D. Jenkins, P. R. Contag, and R. S. Negrin, " Use of reporter genes for optical measurements of neoplastic disease in vivo.," Neoplasia 2 (1-2), 41-52 (2000). 10.1038/sj.neo.7900079 (Pubitemid 30123179)
6. M. Edinger, Y. A. Cao, M. R. Verneris, M. H. Bachman, C. H. Contag, and R. S. Negrin, " Revealing lymphoma growth and the efficacy of immune cell therapies using in vivo bioluminescence imaging.," Blood 101 (2), 640-648 (2003). 10.1182/blood-2002-06-1751 (Pubitemid 36077588)
7. A. Wetterwald, G. Van Der Pluijm, I. Que, B. Sijmons, J. Buijs, M. Karperien, C. W. Lowik, E. Gautschi, G. N. Thalmann, and M. G. Cecchini, " Optical imaging of cancer metastasis to bone marrow: a mouse model of minimal residual disease.," Am. J. Pathol. 160 (3), 1143-1153 (2002). (Pubitemid 34224600)
8. M. Vooijs, J. Jonkers, S. Lyons, and A. Berns, " Noninvasive imaging of spontaneous retinoblastoma pathway-dependent tumors in mice.," Cancer Res. 62 (6), 1862-1867 (2002). (Pubitemid 34408514)
9. D. E. Jenkins, Y. Oei, Y. S. Hornig, S. F. Yu, J. Dusich, T. Purchio, and P. R. Contag, " Bioluminescent imaging (BLI) to improve and refine traditional murine models of tumor growth and metastasis.," Clin. Exp. Metastasis 20 (8), 733-744 (2003). 10.1023/B:CLIN.0000006815.49932.98 (Pubitemid 38019275)
10. J. W. Kang, P. Kim, C. A. Alonzo, H. Park, and S. H. Yun, " Two-photon microscopy by wavelength-swept pulses delivered through single-mode fiber.," Opt. Lett. 35 (2), 181-183 (2010). 10.1364/OL.35.000181
11. P. Kim, E Chung, H. Yamashita, K. E. Hung, A. Mizoguchi, R Kucherlapati, D. Fukumura, R. K. Jain, and S. H. Yun, " In vivo wide-area cellular imaging by side-view endomicroscopy.," Nat. Meth. 7 (4), 303-305 (2010). 10.1038/nmeth.1440
12. I. B. Mazo and U. H. von Andrian, " Adhesion and homing of blood-borne cells in bone marrow microvessels.," J. Leukoc. Biol. 66 (1), 25-32 (1999). (Pubitemid 29321366)
13. J. S. Condeelis, J. Wyckoff, and J. E. Segall, " Imaging of cancer invasion and metastasis using green fluorescent protein.," Eur. J. Cancer 36 (13), 1671-1680 (2000). 10.1016/S0959-8049(00)00155-6 (Pubitemid 30616371)
14. A. F. Chambers, I. C. MacDonald, E. E. Schmidt, V. L. Morris, and A. C. Groom, " Preclinical assessment of anticancer therapeutic strategies using in vivo videomicroscopy.," Cancer Metastasis. Rev. 17 (3), 263-269 (1998-1999). 10.1023/A:1006136428254 (Pubitemid 29210165)
15. G. N. Naumov, S. M. Wilson, I. C. MacDonald, E. E. Schmidt, V. L. Morris, A. C. Groom, R. M. Hoffman, and A. F. Chambers, " Cellular expression of green fluorescent protein, coupled with high-resolution in vivo videomicroscopy, to monitor steps in tumor metastasis.," J. Cell. Sci. 112 (12), 1835-1842 (1999). (Pubitemid 29338809)
16. J. Condeelis and J. E. Segall, " Intravital imaging of cell movement in tumors.," Nat. Rev. Cancer 3 (12), 921-930 (2003). 10.1038/nrc1231 (Pubitemid 37500177)
17. R. K. Jain, " Understanding barriers to drug delivery: high resolution in vivo imaging is key.," Clin. Cancer Res. 5 (7), 1605-1606 (1999). (Pubitemid 29334434)
18. R. M. Hoffman, " Visualization of GFP-expressing tumors and metastasis in vivo.," Biotech. 30 (5), 1016-1026 (2001). (Pubitemid 32429942)
19. E. D. George and R. Sadovsky, " Multiple myeloma: recognition and management.," Am. Fam. Phys. 59 (7), 1885-1894 (1999).
20. R. A. Kyle, T. M. Therneau, S. V. Rajkumar, D. R. Larson, M. F. Plevak, and L. J. Melton, 3rd, " Incidence of multiple myeloma in Olmstead County, Minnesota: trend over six decades.," Cancer 101 (11), 2667-2674 (2004). 10.1002/cncr.20652 (Pubitemid 39532300)
21. L. W. Terstappen, S. Johnsen, I. M. Segers-Nolten, and M. R. Loken, " Identification and characterization of plasma cells in normal human bone marrow by high-resolution flow cytometry.," Blood 76 (9), 1739-1747 (1990).
22. R. A. Kyle and S. V. Rajkumar, " Multiple myeloma.," N. Engl. J. Med. 351 (18), 1860-1873 (2004). 10.1056/NEJMra041875 (Pubitemid 39426321)
23. D. Billadeau, B. Van Ness, T. Kimlinger, R. A. Kyle, T. M. Therneau, P. R. Greipp, and T. E. Witzig, " Clonal circulating cells are common in plasma cell proliferative disorders: a comparison of monoclonal gammopathy of undetermined significance, smoldering multiple myeloma, and active myeloma.," Blood 88 (1), 289-296 (1996). (Pubitemid 26230698)
24. S. Kumar, S. V. Rajkumar, R. A. Kyle, M. Q. Lacy, A. Dispenzieri, R. Fonseca, J. A. Lust, M. A. Gertz, P. R. Greipp, and T. E. Witzig, " Prognostic value of circulating plasma cells in monoclonal gammopathy of undetermined significance.," J. Clin. Oncol. 23 (24), 5668-5674 (2005). 10.1200/JCO.2005.03.159
25. P. Tassone, P. Neri, D. R. Carrasco, R. Burger, V. S. Goldmacher, R. Fram, V. Munshi, M. A. Shammas, L. Catley, G. S. Jacob, S. Venuta, K. C. Anderson, and N. C. Munshi, " A clinically relevant SCID-hu in vivo model of human multiple myeloma.," Blood 106 (2), 713-716 (2005). 10.1182/blood-2005-01-0373 (Pubitemid 40981270)
26. M. Urashima, B P. Chen, S. Chen, G. S. Pinkus, R. T. Bronson, D. A. Dedera, Y. Hoshi, G. Teoh, A. Ogata, S. P. Treon, D. Chauhan, and K. C. Anderson, " The development of a model for the homing of multiple myeloma cells to human bone marrow.," Blood 90 (2), 754-765, (1997). (Pubitemid 27299116)
27. R. LeBlanc, L. P. Catley, T. Hideshima, S. Lentsch, C. S. Mitsiades, N. Mitsiades, D. Neuberg, O. Goloubeva, C. S. Pien, J. Adams, D. Gupta, P. G. Richardson, N. C. Munshi, and K. C. Anderson, " Proteosome inhibitor PS-341 inhibits human myeloma cell growth in vivo and prolongs survival in a murine model.," Cancer Res. 62 (17), 4996-5000 (2002). (Pubitemid 34984425)
28. C. S. Mitsiades, N. S. Mitsiades, R. T. Bronson, D. Chauhan, N. Munshi, S. P. Treon, C. A. Maxwell, L Pilarski, T. Hideshima, R. M. Hoffman, and K. C. Anderson, " Fluorescence imaging of multiple myeloma cells in a clinically relevant SCID/NOD in vivo model: biologic and clinical implications.," Cancer Res. 63 (20), 6689-6696 (2003). (Pubitemid 37322948)
29. C. S. Mitsiades, K. C. Anderson, and D. R. Carrasco, " Mouse models of human myeloma.," Hematol. Oncol. Clin. North Am. 21 (6), 1051-1069 (viii) (2007). 10.1016/j.hoc.2007.08.003 (Pubitemid 350051346)
30. D. A. Sipkins, X. Wei, J. W. Wu, J. M. Runnels, D. Côt́, T. K. Means, A. D. Luster, D. T. Scadden, and C. P. Lin, " In vivo imaging of specialized bone marrow endothelial microdomains for tumour engraftment.," Nature 435 (7044), 969-973 (2005). 10.1038/nature03703 (Pubitemid 40896324)
31. A. Müller, B. Homey, H. Soto, N. Ge, D. Catron, M. E. Buchanan, T. McClanahan, E. Murphy, W. Yuan, S. N. Wagner, J. L. Berrera, A. Mohar, E. Verástegui, and A. Zlotnik, " Involvement of chemokine receptors in breast cancer metastasis.," Nature 410 (6824), 50-56 (2001). 10.1038/35065016 (Pubitemid 32225831)
32. M. Takenaga, H. Tamamura, K. Hiramatsu, N. Nakamura, Y. Yamaguchi, A. Kitagawa, S. Kawai, H. Nakashima, N. Fujii, and R. Igarashi, " A single treatment with microcapsules containing CXCR4 antagonist suppresses pulmonary metastasis of murine melanoma.," Biochem. Biophys. Res. Commun. 320 (1), 226-232 (2004). 10.1016/j.bbrc.2004.05.155 (Pubitemid 38781805)
33. A. Peled, I Petit, O. Kollet, M. Magid, T. Ponomaryov, T. Byk, A. Nagler, H. Ben-Hur, A. Many, L. Shultz, O. Lider, R. Alon, D. Zipori, and T. Lapidot, " Dependence of human stem cell engraftment and repopulation of NOD/SCID mice on CXCR4.," Science 283 (5403), 845-848 (1999). 10.1126/science.283. 5403.845 (Pubitemid 29072324)
34. T. Lapidot and O. Kollet, " The essential roles of the chemokine SDF-1 and its receptor CXCR4 in the human stem cell homing and repopulation of transplanted immune-deficient NOD/SCID and NOD/SCID/B2m(null) mice.," Leukemia 16 (10), 1992-2003 (2002). 10.1038/sj.leu.2402684 (Pubitemid 35203441)
35. Y. Alsayed, H. Ngo, J. Runnels, X. Leleu, U. K. Singha, C. M. Pitsillides, J. A. Spencer, T. Kimlinger, J. M. Ghobrial, X. Jia, G. Lu, M. Timm, A. Kumar, D. Côt́, I. Veilleux, K. E. Hedin, G. D. Roodman, T. E. Witzig, A. L. Kung, T. Hideshima, K. C. Anderson, C. P. Lin, and I. M. Ghobrial, " Mechanisms of regulation of CXCR4/SDF-1 (CXCL12)-dependent migration and homing in multiple myeloma.," Blood 109 (7), 2708-2717 (2007). (Pubitemid 46482062)
36. A. K. Azab, J. M. Runnels, C. Pitsillides, A. S. Moreau, F. Azab, X. Leleu, X. Jia R. Wright, B. Ospina, A. L. Carlson, C. Alt, N. Burwick, A. M. Roccaro, H. T. Ngo, M. Farag, M. R. Melhem, A. Sacco, N. C. Munshi, T. Hideshima, B. J. Rollins, K. C. Anderson, A. L. Kung, C. P. Lin, and I. M. Ghobrial, " The CXCR4 inhibitor AMD3100 disrupts the interaction of multiple myeloma cells with the bone marrow microenvironment and enhances their sensitivity to therapy.," Blood 113 (18), 4341-4351 (2009). 10.1182/blood-2008-10-186668
37. A. Peled, O. Kollet, T. Ponomaryov, I. Petit, S. Franitza, V. Grabovsky, M. M. Slav, A. Nagler, O. Lider, R. Alon, D. Zipori, and T. Lapidot, " The chemokine SDF-1 activates the integrins LFA-1, VLA-4, and VLA-5 on immature human CD34(+) cells: role in transendothelial/stromal migration and engraftment of NOD/SCID mice.," Blood 95 (11), 3289-3296 (2000). (Pubitemid 30428455)
38. E. Tian, F. Zhan, R. Walker, E. Rasmussen, Y. Ma, B. Barlogie, and J. D. Shaughnessy, Jr., " The role of Wnt-signaling antagonist DKK1 in the development of osteolytic lesions in multiple myeloma.," N. Eng. J. Med. 349 (26), 2483-2494 (2003). 10.1056/NEJMoa030847 (Pubitemid 38010074)
39. L. A. Ehrlich, H. Y. Chung, I. Ghobrial, S. J. Choi, F. Morandi, S. Colla, V. Rizzoli, G. D. Roodman, and N. Giuliani, " IL-3 is a potential inhibitor of osteoblast differentiation in multiple myeloma.," Blood 106 (4), 1407-1414 (2005). 10.1182/blood-2005-03-1080 (Pubitemid 41129608)
40. T. Standal, N. Abildgaard, U. M. Fagerli, B. Stordal, O. Hjertner, M. Borset, and A. Sundan, " HGF inhibits BMP-induced osteoblastogenesis: possible implications for the bone disease of multiple myeloma.," Blood 109 (7), 3024-3030 (2006). (Pubitemid 46482103)
41. C. K. Lee, E. S. K. Ma, T. W. H. Shek, C. C. K. Lam, W. Y. Au, T. S. K. Wan, and L. C. Chan, " Plasmablastic transformation of multiple myeloma.," Hum. Pathol. 34 (7), 710-714 (2003). 10.1016/S0046-8177(03) 00181-3 (Pubitemid 36875518)
42. H. Brenner, A. Gondos, and D. Pulte, " Recent major improvements in long-term survival of younger patients with multiple myeloma.," Blood 111 (5), 2521-2526 (2008). 10.1182/blood-2007-08-104984
43. S. K. Kumar, S. V. Rajkumar, A. Dispenzieri, M. Q. Lacy, S. R. Hayman, F. K. Buadi, S. R. Zeldenrust, D. Dingli, S. J. Russell, J. A. Lust, P. R. Greipp, R. A. Kyle, and M. A. Gertz, " Improved survival in multiple myeloma and the impact of novel therapies.," Blood 111 (5), 2516-2520 (2008). 10.1182/blood-2007-10-116129
44. T. Hideshima, P. Richardson, D. Chauhan, V. J. Palombells, P. J. Elliott, J. Adams, and K. C. Anderson, " The proteosome inhibitor PS-341 inhibits growth, induces apoptosis, and overcomes drug resistance in human multiple myeloma cell lines.," Cancer Res. 61 (7), 3071-3076 (2001). (Pubitemid 32691956)
45. T. Hayashi, T. Hideshima, M. Akiyama, K. Podar, H. Yasui, N. Raje, S. Kumar,. D. Chauhan, S. P. Treon, P. Richardson, and K. C. Anderson, " Molecular mechanisms whereby immunomodulatory drugs activate natural killer cells: clinical application.," Br. J. Haematol. 128 (2), 192-203 (2005). 10.1111/j.1365-2141.2004.05286.x
46. S. Kumar, N. Raje, T. Hideshima, K. Ishitsuka, A. Roccaro, N. Shiraishi, M. Hamasaki, H. Yasui, N. C. Munshi, P. Richardson, W. D. Figg, and K. C. Andersn, " Antimyeloma activity of two novel N-substituted and tetrafluorinated thalidomide analogs.," Leukemia 19 (7), 1253-1261 (2005). 10.1038/sj.leu.2403776 (Pubitemid 40946012)
47. K. C. Anderson, " Targeted therapy of multiple myeloma based upon tumor-microenvironmental interactions.," Exp. Hematol. 35 (4 Suppl 1), 155-162 (2007). 10.1016/j.exphem.2007.01.024 (Pubitemid 46427993)
48. J. Adams, " Development of the proteasome inhibitor PS-341.," Oncologist 7 (1), 9-16 (2002). 10.1634/theoncologist.7-1-9 (Pubitemid 34151104)
49. S. Thomas, T. Richards, and D. M. Weber, " Novel Agents for Previously Untreated Multiple Myeloma.," Chap. 8 in Multiple Myeloma: Translational and Emerging Therapies., K. C. Anderson, and, I. M. Ghobrial, Eds., pp. 141-167, Informa Healthcare USA Inc., New York (2008).
50. A. L. Goldberg, " Protein degradation and protection against misfolded or damaged proteins.," Nature 426 (6968), 895-899 (2003). 10.1038/nature02263 (Pubitemid 38056882)
51. H. C. Drexler, " Activation of cell death program by inhibition of proteasome function.," Proc. Natl. Acad. Sci. 94 (3), 855-860 (1997). 10.1073/pnas.94.3.855 (Pubitemid 27074411)
52. J. Delic, P. Masdehors, S. Omura, J. M. Cosset, J. Dumont, J. L. Binet, and H. Magdeĺnat, " The proteasome inhibitor lactacystin induces apoptosis and sensitizes chemo- and radioresistant human chronic lymphocytic leukaemia lymphocytes to TNF-alpha-initiated-apoptosis.," Br. J. Cancer 77 (7), 1103-1107 (1998). (Pubitemid 28116281)
53. Z. Kalajzic, P. Liu, I. Kalajzic, Z. Du, A. Braut, M. Mina, E. Canalis, and D. W. Rowe, " Directing the expression of a green fluorescent protein transgene in differentiated osteoblasts: comparison between rat type I collagen and rat osteocalcin promoters.," Bone 31 (6), 654-660 (2002). 10.1016/S8756-3282(02)00912-2 (Pubitemid 36092087)
54. R. E. Goldman-Leiken, H. R. Salwen, C. V. Herst, D. Variakojis, M. L. Bian, M. M. Le Beau, P. Selvanayagan, R. Marder, R. Anderson, S. Weitzman, and S. T. Rosen, " Characterization of a novel myeloma cell line, MM.1.," J. Lab. Clin. Med. 113 (3), 335-345, (1989). (Pubitemid 19085207)
55. J. Novak, I. Georgakoudi, X. Wei, A. Prossin, and C. P. Lin, " In vivo flow cytometer for real-time detection and quantification of circulating cells.," Opt. Lett. 29 (1), 77-79 (2004). 10.1364/OL.29.000077
56. C. Lo Celso, H. E. Fleming, J. W. Wu, C. X. Zhao, S Miake-Lye, J. Fujisaki, D. Côt́, D. W. Rowe, C. P. Lin, and D. T. Scadden, " Live-animal tracking of individual haematopoietic stem/progenitor cells in their niche.," Nature 457 (7225), 92-96 (2009). 10.1038/nature07434
57. A. Ascenzi and C. Fabry, " Technique for dissection and measurement of refractive index of osteones.," J. Biophys. Biochemic. Cytol. 6 (1), 139-142 (1959). 10.1083/jcb.6.1.139
58. H. Uchiyama, B. A. Barut, D. Chauhan, S. A. Cannistra, and K. C. Anderson, " Characterization of adhesion molecules on human myeloma cell lines.," Blood 80 (9), 2306-2314 (1992).
59. J. R. MacDougall, B. A. Croy, C. Chapeau, and D. A. Clark, " Demonstration of a splenic cytotoxic effector cell in mice of genotype SCID/SCID.BG/BG.," Cell Immunol. 130 (1), 106-117 (1990). 10.1016/0008-8749(90)90165-N (Pubitemid 20329269)
60. J. Folkman, " Seminars in Medicine of the Beth Isreal Hospital, Boston. Clinical applications of research on angiogenesis.," N. Engl. J. Med. 333 (26), 1757-1763 (1995). 10.1056/NEJM199512283332608 (Pubitemid 26009687)
61. S. Paget, " The distribution of secondary growths in cancer of the breast. 1889.," (republication of Paget's 1889 Lancet article). Cancer Metastsis Rev. 8 (2), 98-101 (1989).
62. M. A. Swartz, M. Skobe, " Lymphatic function, lymphangiogenesis, and cancer metastasis.," Microsc. Res. Tech. 55 (2), 92-97 (2001).
63. T. Hideshima, C. Mitsiades, G. Tonon, P. G. Richardson, and K. C. Anderson, " Understanding multiple myeloma pathogenesis in the bone marrow to identify new targets.," Nat. Rev. Cancer 7 (8), 585-598 (2007). 10.1038/nrc2189 (Pubitemid 47106630)
64. G. D. Roodman, " Novel targets for myeloma bone disease.," Expert Opin. Ther. Targets 12 (11), 1377-1387 (2008). 10.1517/14728222.12.11. 1377
65. D. Chauhan, A. V., Singh, M. Brahmandam, R. Carrasco, M. Bandi, T. Hideshima, G. Bianchi, K. Podar, YT. Tai, C. Mitsiades, N. Raje, D. L. Jaye. S. K. Kumar, P. Richardson, N. Munshi, and K. C. Anderson, " Functional interaction of plasmacytoid dendritic cells with multiple myeloma cells: a therapeutic target.," Cancer Cell 16 (4), 309-323 (2009). 10.1016/j.ccr.2009.08.019
66. J. E. Dick, " Stem cell concepts renew cancer research.," Blood 112 (13), 4793-4807 (2008). 10.1182/blood-2008-08-077941
67. W. Matsui, C. A. Huff, Q. Wang, M. T. Malehorn, J. Barber, Y. Tanhehco, B. D. Smith, C. I. Civin, and R. J. Jones, " Characterization of clonogenic multiple myeloma cells.," Blood 103 (6), 2332-2336 (2004). 10.1182/blood-2003-09-3064 (Pubitemid 38326254)
68. S. Riethdorf, H. Wikman, and K. Pantel, " Review: Biological relevance of disseminated tumor cells in cancer patients.," Int. J. Cancer 123 (9), 1991-2006 (2008). 10.1002/ijc.23825
69. M. Suzuki, E. S. Mose, V. Montel, and D. Tarin, " Dormant cancer cells retrieved from metastasis-free organs regain tumorigenic and metastatic potency.," Am. J. Pathol. 169 (2), 673-681 (2006). 10.2353/ajpath.2006. 060053 (Pubitemid 44156323)
70. G. N. Naumov, J. L. Townson, I. C. MacDonald, S. M. Wilson, V. H. Bramwell, A. C. Groom, and A. F. Chambers, " Ineffectiveness of doxorubicin treatment on solitary dormant mammary carcinoma cells or late-developing metastases.," Breast Cancer Res. Treat. 82 (3), 199-206 (2003). 10.1023/B:BREA.0000004377.12288.3c (Pubitemid 37521976)